J.A. Haas

961 total citations
53 papers, 711 citations indexed

About

J.A. Haas is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Cancer Research. According to data from OpenAlex, J.A. Haas has authored 53 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Radiation and 10 papers in Cancer Research. Recurrent topics in J.A. Haas's work include Advanced Radiotherapy Techniques (23 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Prostate Cancer Treatment and Research (16 papers). J.A. Haas is often cited by papers focused on Advanced Radiotherapy Techniques (23 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Prostate Cancer Treatment and Research (16 papers). J.A. Haas collaborates with scholars based in United States and Netherlands. J.A. Haas's co-authors include M.R. Witten, S A Sedman, William C. Vass, Douglas R. Lowy, John T. Schiller, N L Hubbert, Miguel Barbosa, Shelia Pozorski, Thomas Pozorski and John V. Murra and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

J.A. Haas

48 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. Haas United States 13 185 172 162 147 135 53 711
Binglan Zhang China 17 51 0.3× 187 1.1× 147 0.9× 401 2.7× 65 0.5× 39 986
G. Louvel France 15 65 0.4× 95 0.6× 33 0.2× 95 0.6× 187 1.4× 49 643
Stefano Ricci Italy 16 62 0.3× 279 1.6× 26 0.2× 273 1.9× 17 0.1× 67 860
Vassilis Koutoulidis Greece 19 52 0.3× 318 1.8× 21 0.1× 222 1.5× 15 0.1× 78 1.1k
David C. Weksberg United States 12 111 0.6× 288 1.7× 119 0.7× 260 1.8× 95 0.7× 18 1.6k
Vivian Weinberg United States 18 131 0.7× 338 2.0× 185 1.1× 294 2.0× 146 1.1× 28 1.2k
Wui‐Jin Koh United States 16 171 0.9× 352 2.0× 110 0.7× 382 2.6× 122 0.9× 44 1.3k
Lia M. Halasz United States 16 180 1.0× 140 0.8× 108 0.7× 217 1.5× 103 0.8× 69 850
Ulrike Mock Austria 10 48 0.3× 179 1.0× 70 0.4× 74 0.5× 212 1.6× 21 570
Jürgen Krauß Germany 19 136 0.7× 197 1.1× 78 0.5× 304 2.1× 38 0.3× 61 1.1k

Countries citing papers authored by J.A. Haas

Since Specialization
Citations

This map shows the geographic impact of J.A. Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Haas more than expected).

Fields of papers citing papers by J.A. Haas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Haas. The network helps show where J.A. Haas may publish in the future.

Co-authorship network of co-authors of J.A. Haas

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Haas. A scholar is included among the top collaborators of J.A. Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Haas. J.A. Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becker, Anton S., Aaron E. Katz, Angela Tong, et al.. (2025). Low incidence of significant hydrogel spacer rectal wall infiltration: results from an experienced high-volume center. Frontiers in Oncology. 15. 1563015–1563015.
2.
Lischalk, Jonathan W., Meredith Akerman, Michael Repka, et al.. (2024). High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation. Frontiers in Oncology. 14. 1325200–1325200.
3.
4.
Haas, J.A., Meredith Akerman, Moses Tam, et al.. (2023). Stereotactic Body Radiation Therapy for the Curative Treatment of Prostate Cancer in Ultralarge (≥100 cc) Glands. Practical Radiation Oncology. 14(3). 241–251. 3 indexed citations
5.
Leu, Justin, Meredith Akerman, Christopher Mendez, et al.. (2023). Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure. Frontiers in Oncology. 13. 1132777–1132777. 3 indexed citations
6.
Lischalk, Jonathan W., et al.. (2022). Robotic Stereotactic Body Radiation Therapy for the Adjuvant Treatment of Early-Stage Breast Cancer: Outcomes of a Large Single-Institution Study. Advances in Radiation Oncology. 8(2). 101095–101095. 2 indexed citations
7.
Okpara, Chinyere E., et al.. (2022). Comparative results of focal-cryoablation and stereotactic body radiotherapy in the treatment of unilateral, low-to-intermediate-risk prostate cancer. International Urology and Nephrology. 54(10). 2529–2535. 3 indexed citations
8.
Haas, J.A., et al.. (2020). Translating the Immunobiology of SBRT to Novel Therapeutic Combinations for Advanced Prostate Cancer. Frontiers in Oncology. 10. 830–830. 4 indexed citations
9.
Repka, Michael, et al.. (2020). Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT. Frontiers in Oncology. 10. 203–203. 4 indexed citations
10.
Werneburg, Glenn T., Michael Kongnyuy, Daniel Halpern, et al.. (2017). Patient-reported quality of life progression in men with prostate cancer following primary cryotherapy, cyberknife, or active holistic surveillance. Prostate Cancer and Prostatic Diseases. 21(3). 355–363. 2 indexed citations
12.
Witten, M.R., et al.. (2015). Integrating Bone Targeting Radiopharmaceuticals Into the Management of Patients With Castrate-Resistant Prostate Cancer With Symptomatic Bone Metastases. Current Treatment Options in Oncology. 16(3). 325–325. 7 indexed citations
13.
Haas, J.A., et al.. (2014). Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer. Frontiers in Oncology. 4. 8–8. 25 indexed citations
14.
Schneider, Jeffrey, et al.. (2014). Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Small Academic Hospital Experience. Frontiers in Oncology. 4. 287–287. 7 indexed citations
15.
Suh, Jason, et al.. (2013). Coronary Calcium Scanning in Patients after Adjuvant Radiation for Early Breast Cancer and Ductal Carcinoma In situ. Frontiers in Oncology. 3. 253–253. 11 indexed citations
16.
Haas, J.A., et al.. (2012). CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy. SHILAP Revista de lepidopterología. 2. 25–25. 72 indexed citations
17.
Katz, Aaron E., et al.. (2012). Treatment of Prostate Cancer Local Recurrence After Whole-Gland Cryosurgery With Frameless Robotic Stereotactic Body Radiotherapy: Initial Experience. Clinical Genitourinary Cancer. 11(2). 89–93. 6 indexed citations
18.
Reardon, Michael J., et al.. (2003). A Combined Modality Approach to Recurrent Cardiac Sarcoma Resulting in a Prolonged Remission. CHEST Journal. 123(5). 1766–1768. 12 indexed citations
19.
Markiewicz, Deborah A., Delray J. Schultz, J.A. Haas, et al.. (1996). The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. International Journal of Radiation Oncology*Biology*Physics. 35(4). 661–668. 94 indexed citations
20.
Jansen, E.N.H., et al.. (1992). Parlodel SRO in Parkinson’s Disease: A Double-Blind Randomized Comparison of Parlodel Standard and Parlodel SRO. European Neurology. 32(6). 318–320. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026